Welcome to the Braddock Lab

Braddock Lab Group
We study the pathophysiology of benign and malignant hematologic disorders using biochemical and biophysical methods. Recently, we uncovered two endothelial bound enzymes on the cerebral vasculature that induce platelet aggregation via the hydrolysis of a small molecule released by platelets upon degranulation. We have proposed that these enzymes are unrecognized factors capable of inducing central hemostasis/stroke, a hypothesis supported by recent genomic studies revealing genes conferring stroke protection to patients at risk for thrombotic stroke (see press release).

Lab News

single-column-thumbnailsphotobooksOrgId=114524/WCF/News.svc/5